|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 CNY | -5.56% |
|
-.--% | -78.48% |
Guangdong Taiantang Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 410.36 million compared to CNY 645.53 million a year ago. Net loss was CNY 2,210.09 million compared to CNY 968.16 million a year ago.
Basic loss per share from continuing operations was CNY 2.88 compared to CNY 1.26 a year ago. Diluted loss per share from continuing operations was CNY 2.88 compared to CNY 1.26 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -78.48% | 54.06M | |
| +43.31% | 6.19B | |
| -16.99% | 4.48B | |
| +6.39% | 3.29B | |
| -13.10% | 3.12B | |
| -4.17% | 2.5B | |
| +45.47% | 1.94B | |
| -9.11% | 1.68B | |
| -2.09% | 1.64B | |
| -12.50% | 1.56B |
GUANGDONG TAIANTANG PHARMACEUTICAL CO., LTD. 
